greeksoup/ stock research

AdaptHealth (AHCO) FY2023 results: revenue $3.2 billion, up 7.7% on the year

AdaptHealth Corp. (AHCO) reported revenue of $3.2 billion for fiscal 2023, the year ended 31 December 2023, up 7.7% on the year before. Net income was -$679 million, and diluted earnings per share $-5.31. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2024.

Revenue
$3.2 billion
+7.7% on the year
FY2018FY2023
Operating margin
-18.7%
6.4% a year earlier
FY2018FY2023
Net income
-$679 million
FY2018FY2023
Diluted EPS
-$5.31
FY2018FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue3,2002,9712,455+7.7%
Cost of revenue2,5762,3902,009+7.8%
Gross profit624580446+7.6%
Gross margin19.5%19.5%18.2%
Operating income-598190226
Operating margin-18.7%6.4%9.2%
Interest expense13010995.2+19.1%
Pre-tax income-72497.9191
Income tax-49.024.832.8
Effective tax raten/a25.3%17.2%
Net income-67969.3156
Net margin-21.2%2.3%6.4%
Diluted EPS-$5.31$0.33$0.67
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow481374276+28.6%
Capital expenditure337391203-13.8%
Free cash flow143-17.672.4
Free cash flow margin4.5%-0.6%2.9%
Cash from investing-357-411-1,825
Cash from financing-92.5-66.11,599
Depreciation and amortisation383351258+9.0%
Share-based compensation22.522.425.3+0.3%
Buybacks29.314.00.0+109.2%
Diluted shares, weighted134m139m133m-3.3%
Shares outstanding at period end133m134m134m-1.3%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity1,4582,1512,062-32.2%
Non-controlling interest8.26.64.8+24.5%
Debt2,1482,1882,204-1.8%
Operating lease liabilities85.5104120-18.1%
Finance lease liabilities22.74.00.1+475.8%
Other liabilities786765860+2.7%
Total liabilities and equity4,5095,2205,250-13.6%
Fixed assets495n/a399
Goodwill2,7253,5453,513-23.1%
Intangible assets130163202-20.0%
Cash and equivalents77.146.3150+66.7%
Receivables389359360+8.3%
Inventory114128123-11.0%
Other assets579978504-40.8%
Total assets4,5095,2205,250-13.6%

10-K for the year ended 31 December 2023, filed 27 February 2024: the filing.